Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 1

Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.

881 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 1 trial results

Completed

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

NCT00129259

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • The Diabetes Center at UCSF San Francisco, California, United States
  • Barbara Davis Center for Childhood Diabetes Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • Medical College of Georgia Augusta, Georgia, United States
View Trial Details
Completed

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

NCT01950650

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations
  • Novo Nordisk Investigational Site Princeton, New Jersey, United States
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Paris La Défense Cedex, France
  • Novo Nordisk Investigational Site Mainz, Germany
View Trial Details
Completed

Young With Diabetes Type 1 - Test of an mHealth App

NCT02632383

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Steno Diabetes Center Gentofte Municipality, Gentofte, Denmark
  • Pediatric and Adolescent Department, Herlev Hospital Herlev, Denmark
  • Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød Hillerød, Denmark
  • Pediatric and Adolescent Department, Nordsjællands Hospital, Hillerød Hillerød, Denmark
View Trial Details
Completed

Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes

NCT00982228

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
  • Novo Nordisk Investigational Site Concord, California, United States
View all 91 locations
View Trial Details
Completed

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

NCT00773279

Conditions
Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations
  • Novo Nordisk Investigational Site Burlingame, California, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Encino, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 65 locations
View Trial Details
Completed

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

NCT00978627

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site La Mesa, California, United States
  • Novo Nordisk Investigational Site Lancaster, California, United States
  • Novo Nordisk Investigational Site Mission Hills, California, United States
  • Novo Nordisk Investigational Site North Hollywood, California, United States
View all 81 locations
View Trial Details

Related conditions